LON:COG Cambridge Cognition (COG) Share Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free COG Stock Alerts GBX 52 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range 51.51▼ 52.8850-Day Range 49.70▼ 57.8952-Week Range 47.23▼ 104Volume49,034 shsAverage Volume61,309 shsMarket Capitalization£18.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Cambridge Cognition alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Cambridge Cognition Stock (LON:COG)Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.Read More COG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart COG Stock News HeadlinesApril 23, 2024 | lse.co.ukCambridge Cognition partly-owned spin-off gets GBP1.5 million fundingApril 21, 2024 | thetimes.co.ukCambridge in free-speech row over researcher’s ‘race realism’ blogApril 23, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 17, 2024 | msn.comSage Therapeutics stock plunges 23 percent after Parkinson’s drug fails studyApril 17, 2024 | bizjournals.comSage halts trials in Parkinson’s after drug fails to show benefitApril 17, 2024 | msn.comAI speeds up drug design for Parkinson's by ten-foldApril 17, 2024 | msn.comA window into Alzheimer's and early detection - how regular eye exams could helpApril 15, 2024 | news.yahoo.comVision changes could predict dementia 12 years before diagnosis, study saysApril 23, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 11, 2024 | msn.com11 Greater Boston residents win Guggenheim Fellowships this yearApril 5, 2024 | yahoo.comTypes of dementia: From vascular to Alzheimer’sApril 3, 2024 | uk.news.yahoo.comHow food preferences are linked to cognition and brain health – and why a balanced diet is superiorApril 1, 2024 | msn.comThere’s a Reason They’re Called ‘Gut’ FeelingsApril 1, 2024 | msn.com"Beyond Words" brings actor's portrayal of a Harvard professor's parrot to Cambridge stageApril 1, 2024 | msn.comThese 79 Memes Are Just What You Need to Take a Break and Have a Giggle (New Pics)April 1, 2024 | msn.comDementia hope as scientists say jab could be huge 'breakthrough'April 1, 2024 | msn.comComforting hospital cat 'sucks up the negativity'April 1, 2024 | msn.comNew wonder jab to prevent dementia available on NHS in FIVE years - 'Massive breakthrough'March 31, 2024 | msn.comHuge Alzheimer's breakthrough as scientists say new jab could 'transform' livesMarch 31, 2024 | mirror.co.ukMajor Alzheimer's breakthrough as new vaccine could 'transform' lives, scientists sayMarch 29, 2024 | yahoo.comGoogle DeepMind CEO Demis Hassabis gets UK knighthood for 'services to artificial intelligence'March 29, 2024 | msn.comIt's Tricky to Know Which Supplements Are Safe — Here's What to AvoidMarch 28, 2024 | msn.comCanadian rower looking forward to third outing for Oxford in historic Boat RaceMarch 28, 2024 | msn.comChronic alcohol use is linked to impaired plasticity of brain inhibition networks, study suggestsMarch 21, 2024 | msn.comMemory-Boosting Supplements Could Lack Compounds and Contain BacteriaMarch 17, 2024 | msn.comI’ll do it later: my quest to stop procrastinatingMarch 17, 2024 | mirror.co.uk'Our brains compensate for decline as we grow older by recruiting other areas'See More Headlines Receive COG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Cognition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/22/2020Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:COG CUSIPN/A CIKN/A Webwww.cambridgecognition.com Phone44 1223 810 700FaxN/AEmployees80Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.11) Trailing P/E RatioN/A Forward P/E Ratio37.97 P/E GrowthN/ANet Income£-3,740,000.00 Net Margins-29.25% Pretax MarginN/A Return on Equity-630.55% Return on Assets-13.31% Debt Debt-to-Equity Ratio18.95 Current Ratio0.45 Quick Ratio0.96 Sales & Book Value Annual Sales£12.77 million Price / Sales1.42 Cash FlowGBX 12.07 per share Price / Cash Flow4.31 Book ValueGBX 3 per share Price / Book17.33Miscellaneous Outstanding Shares34,960,000Free FloatN/AMarket Cap£18.18 million OptionableNot Optionable Beta0.76 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. Matthew William Stork (Age 56)CEO & Director Comp: $342kMr. Stephen Daniel Symonds (Age 49)CFO & Executive Director Comp: $203.31kMr. John HammondCo-FounderMr. Nick TaptiklisHead of Technology StrategyMs. Francesca Cormack Ph.D.Chief Scientist & Member of Scientific Advisory BoardMr. Simon MerrittMarketing and Communications DirectorDr. Lisa Elizabeth Nolan Ph.D. (Age 62)Vice President Business Development Ms. Nicky AckerleyGlobal HR DirectorProf. Trevor Robbins CBEFBPsS, FMedSci, FRS, Ph.D., Senior ConsultantProf. Barbara Sahakian FBPsSFMedSci, Senior ConsultantMore ExecutivesKey CompetitorsFeedbackLON:FDBKInduction Healthcare GroupLON:INHCRenalytixLON:RENXOxford BioDynamicsLON:OBDDestiny PharmaLON:DESTView All Competitors COG Stock Analysis - Frequently Asked Questions How have COG shares performed in 2024? Cambridge Cognition's stock was trading at GBX 51.50 on January 1st, 2024. Since then, COG shares have increased by 1.0% and is now trading at GBX 52. View the best growth stocks for 2024 here. How were Cambridge Cognition's earnings last quarter? Cambridge Cognition Holdings Plc (LON:COG) released its quarterly earnings data on Tuesday, September, 22nd. The company reported ($1.50) earnings per share (EPS) for the quarter. Cambridge Cognition had a negative trailing twelve-month return on equity of 630.55% and a negative net margin of 29.25%. What other stocks do shareholders of Cambridge Cognition own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cambridge Cognition investors own include Interserve (IRV), Alio Gold Inc. (ALO.TO) (ALO), Concepta PLC (CPT.L) (CPT), European Metals (EMH), IntelGenx Technologies (IGXT), Oxford Biomedica (OXB), Syneos Health (SYNH), Travelers Companies (TRV), Amryt Pharma (AMYT) and AltynGold (ALTN). How do I buy shares of Cambridge Cognition? Shares of COG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:COG) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Cognition Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
